GB9900078D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9900078D0
GB9900078D0 GBGB9900078.8A GB9900078A GB9900078D0 GB 9900078 D0 GB9900078 D0 GB 9900078D0 GB 9900078 A GB9900078 A GB 9900078A GB 9900078 D0 GB9900078 D0 GB 9900078D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9900078.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9900078.8A priority Critical patent/GB9900078D0/en
Publication of GB9900078D0 publication Critical patent/GB9900078D0/en
Priority to PCT/GB1999/004351 priority patent/WO2000040574A1/en
Priority to AU30605/00A priority patent/AU3060500A/en
Priority to EP99964753A priority patent/EP1140891A1/en
Priority to JP2000592282A priority patent/JP2003507323A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GBGB9900078.8A 1999-01-05 1999-01-05 Chemical compounds Ceased GB9900078D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9900078.8A GB9900078D0 (en) 1999-01-05 1999-01-05 Chemical compounds
PCT/GB1999/004351 WO2000040574A1 (en) 1999-01-05 1999-12-21 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
AU30605/00A AU3060500A (en) 1999-01-05 1999-12-21 1,4-diazacycloheptane compounds, process for their preparation, and their use asmedicaments
EP99964753A EP1140891A1 (en) 1999-01-05 1999-12-21 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments
JP2000592282A JP2003507323A (en) 1999-01-05 1999-12-21 1,4-diazacycloheptane compound, method for producing the same and use thereof as a drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9900078.8A GB9900078D0 (en) 1999-01-05 1999-01-05 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9900078D0 true GB9900078D0 (en) 1999-02-24

Family

ID=10845530

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9900078.8A Ceased GB9900078D0 (en) 1999-01-05 1999-01-05 Chemical compounds

Country Status (5)

Country Link
EP (1) EP1140891A1 (en)
JP (1) JP2003507323A (en)
AU (1) AU3060500A (en)
GB (1) GB9900078D0 (en)
WO (1) WO2000040574A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375005A (en) * 2019-08-16 2021-02-19 国药集团工业有限公司 Racemization method of ketamine, its derivative or its salt

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914015D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
GB9914025D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
US7923444B2 (en) 2005-02-10 2011-04-12 Neurosearch A/S Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2064514B (en) * 1979-10-29 1984-01-18 Maruko Pharmaceutical Co Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
DE3823533A1 (en) * 1988-07-12 1990-02-08 Beiersdorf Ag SUBSTITUTED 4-HETEROCYCLYL-2H-BENZO (B) PYRANEES, METHOD AND 4-HYDROXY-3-BROM, 3,4-OXIRANYL-3,4-DEHYDRO-2H-BENZO (B) PYRANES AS INTERMEDIATE PRODUCTS FOR THEIR MANUFACTURE, AND THE INVENTION PHARMACEUTICAL PRECAUTIONS CONTAINING THEM
FR2687401B1 (en) * 1992-02-18 1994-05-20 Meram Laboratoires 1,4-DIALKYLPIPERAZINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
KR20000022380A (en) * 1996-07-01 2000-04-25 둘락 노먼 씨. Muscarinic antagonists
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375005A (en) * 2019-08-16 2021-02-19 国药集团工业有限公司 Racemization method of ketamine, its derivative or its salt

Also Published As

Publication number Publication date
AU3060500A (en) 2000-07-24
EP1140891A1 (en) 2001-10-10
WO2000040574A1 (en) 2000-07-13
JP2003507323A (en) 2003-02-25

Similar Documents

Publication Publication Date Title
GB9907658D0 (en) Chemical compounds
GB9902461D0 (en) Chemical compounds
GB9909409D0 (en) Chemical compounds
GB9903861D0 (en) Chemical compounds
GB9910104D0 (en) Chemical compounds
GB9914025D0 (en) Chemical compounds
GB9910110D0 (en) Chemical compounds
GB9900078D0 (en) Chemical compounds
GB9914015D0 (en) Chemical compounds
GB9910394D0 (en) Chemical compounds
GB9914024D0 (en) Chemical compounds
GB9910419D0 (en) Chemical compounds
GB9914022D0 (en) Chemical compounds
GB9908355D0 (en) Chemical compounds
GB9909582D0 (en) Chemical compounds
GB9903860D0 (en) Chemical compounds
GB9909408D0 (en) Chemical compounds
GB9905463D0 (en) Chemical compounds
GB9905462D0 (en) Chemical compounds
GB9909442D0 (en) Chemical compounds
GB9906564D0 (en) Chemical compounds
GB9903853D0 (en) Chemical compounds
GB9906565D0 (en) Chemical compounds
GB9909668D0 (en) Chemical compounds
GB9903857D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)